Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
PTLA

Portola Pharmaceuticals

$30.74

-7.03 (-18.61%)

07:38
08/10/18
08/10
07:38
08/10/18
07:38
Recommendations
Portola Pharmaceuticals analyst commentary at Citi »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Aug

PTLA

Portola Pharmaceuticals

$30.74

-7.03 (-18.61%)

07:10
08/10/18
08/10
07:10
08/10/18
07:10
Recommendations
Portola Pharmaceuticals analyst commentary at Oppenheimer »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Aug

PTLA

Portola Pharmaceuticals

$30.74

-7.03 (-18.61%)

07:06
08/10/18
08/10
07:06
08/10/18
07:06
Downgrade
Portola Pharmaceuticals rating change at Credit Suisse »

Portola Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Aug

PTLA

Portola Pharmaceuticals

$30.74

-7.03 (-18.61%)

05:49
08/10/18
08/10
05:49
08/10/18
05:49
Downgrade
Portola Pharmaceuticals rating change at Credit Suisse »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Aug

PTLA

Portola Pharmaceuticals

$37.77

0.14 (0.37%)

08:05
08/09/18
08/09
08:05
08/09/18
08:05
Earnings
Portola Pharmaceuticals reports Q2 EPS ($1.61), consensus ($1.49) »

Reports Q2 revenue $4M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

  • 25

    Aug

PTLA

Portola Pharmaceuticals

$37.77

0.14 (0.37%)

, CELG

Celgene

$91.23

0.92 (1.02%)

08:04
08/09/18
08/09
08:04
08/09/18
08:04
Hot Stocks
Portola Pharmaceuticals names Ernie Meyer as CHRO »

Portola Pharmaceuticals…

PTLA

Portola Pharmaceuticals

$37.77

0.14 (0.37%)

CELG

Celgene

$91.23

0.92 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

  • 25

    Aug

  • 29

    Oct

PTLA

Portola Pharmaceuticals

$36.55

-0.28 (-0.76%)

08:11
08/03/18
08/03
08:11
08/03/18
08:11
Hot Stocks
Portola Pharmaceuticals' Andexxa granted NTAP status by CMS »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

PTLA

Portola Pharmaceuticals

$41.42

-0.31 (-0.74%)

08:37
07/27/18
07/27
08:37
07/27/18
08:37
Hot Stocks
Portola Pharmaceuticals says CHMP maintains negative opinion on betrixaban »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
PTLA

Portola Pharmaceuticals

$38.21

0.44 (1.16%)

08:36
07/03/18
07/03
08:36
07/03/18
08:36
Hot Stocks
Portola Pharmaceuticals approves grant of an inducement stock option »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTLA

Portola Pharmaceuticals

$41.22

-2.07 (-4.78%)

07:16
06/14/18
06/14
07:16
06/14/18
07:16
Recommendations
Portola Pharmaceuticals analyst commentary at Citi »

Portola not planning sale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.